Sector ratings Monte Rosa Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 11:35:04 2026-06-30 EDT			5-day change	1st Jan Change
24.45 ^USD	+2.30%		+17.09%	+54.66%

06-29	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 2500 Growth Benchmark	CI
06-29	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell Microcap Value Benchmark Index	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
MONTE ROSA THERAPEUTICS, INC.	2.02B	-	B	-	-
LONZA GROUP AG	46.62B		AAA
REVOLUTION MEDICINES, INC.	40.95B	-	B	-	-
IQVIA HOLDINGS INC.	32.26B		AAA
BEONE MEDICINES AG	32.24B		-
CELLTRION, INC.	25.53B		A
ASCENDIS PHARMA A/S	16.38B	-	-	-	-
MEDPACE HOLDINGS, INC.	15.27B		BBB
EUROFINS SCIENTIFIC SE	13.61B		AA
IONIS PHARMACEUTICALS, INC.	13.34B	-	A	-	-
ICON PUBLIC LIMITED COMPANY	13.25B		AAA
BIO-TECHNE CORPORATION	11.05B		AA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	10.87B		AA
TEMPUS AI, INC.	10.47B		A		-
APOGEE THERAPEUTICS, INC.	9.94B	-	B	-	-
ALKERMES PLC	8.76B		A
PRAXIS PRECISION MEDICINES, INC.	9.77B	-	B	-	-
KYMERA THERAPEUTICS, INC.	8.99B	-	BBB	-	-
QIAGEN N.V.	8.23B		AAA
IMMUNOVANT, INC.	7.91B	-	BB	-	-
Average	16.87B		A
Weighted average by Cap.			A